The sensitivity of the miRNA panel in detecting HCC in patients with LC was higher than that of AFP (cut-off value 20 ng/mL) (81.6 vs. 57.3%), while the specificity of the miRNA panel was similar to that of AFP (84.6 vs. 79.5%). The gene discussed is AFP; the disease is hepatocellular carcinoma.